文献速递角膜与眼表疾病

局部应用咪唑立宾抑制小鼠干眼中CD4+ T细胞介导的发病机制

Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究在小鼠干燥应激模型中局部应用咪唑立宾(MZR)滴眼液,观察其对干眼眼表CD4+ T细胞介导免疫及上皮损伤的影响。结果显示MZR组较溶剂对照组泪液分泌增加、杯状细胞丢失减少、角膜屏障功能改善,并抑制角膜上皮MMP-9表达和眼表凋亡,减少CD4+ T细胞浸润及IFN-γ、IL-17A产生,增加IL-13产生。结论认为局部MZR可减轻干眼眼表上皮损伤和CD4+ T细胞介导的免疫。

要点

  • 局部MZR滴眼可增加干燥应激小鼠泪液分泌并改善角膜屏障功能。
  • MZR减少结膜杯状细胞丢失,抑制角膜上皮MMP-9表达和眼表凋亡。
  • MZR减少结膜CD4+ T细胞浸润,降低IFN-γ和IL-17A,增加IL-13。

核心结论

  • 局部应用MZR可减轻干眼眼表上皮损伤和CD4+ T细胞介导的免疫。

研究设计与样本

  • 小鼠干燥应激模型,局部给予MZR或溶剂滴眼液进行对照研究。

主要发现

  • 与溶剂对照组相比,MZR组泪液分泌增加、杯状细胞丢失减少、角膜屏障功能改善。
  • MZR抑制角膜上皮MMP-9表达和眼表凋亡,对结膜TNF-α和IL-1β产生无明显影响。
  • MZR减少结膜CD4+ T细胞浸润,降低IFN-γ和IL-17A产生,增加IL-13产生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigate the effect of topical application of mizoribine (MZR) eye drops on CD4+ T-cell-mediated immunity and epithelial damage in ocular surface of dry eye disease (DED). METHODS: Topical application of MZR or vehicle eye drops was performed in mice subjected to desiccating stress (DS). The phenol red cotton test was used to measure tear production, and Oregon-green-dextran (OGD) staining was performed to assess corneal epithelial barrier function. PAS staining was used to quantify conjunctival goblet cells. Immunofluorescent staining and quantitative (q) RT-PCR were used to assess the expression of matrix metalloproteinase (MMP)-9 in corneal epithelium. qRT-PCR and ELISA were used to assess the production of TNF-α and IL-1β in conjunctiva. Apoptosis in ocular surface was assessed by TUNEL and activation of caspase-8. CD4+ T-cell-mediated immunity was evaluated by CD4 immunohistochemistry and production of T helper cytokines, including IFN-γ, IL-13, and IL-17A in conjunctiva. RESULTS: Compared to vehicle control mice, topical MZR-treated mice showed increased tear production, decreased goblet cell loss, and improved corneal barrier function. Topical application of MZR suppressed the expression of MMP-9 in corneal epithelium and apoptosis in ocular surface, while it had no obvious effect on production of TNF-α and IL-1β in conjunctiva. Topical application of MZR decreased CD4+ T cells infiltration, with decreased production of IFN-γ and IL-17A, and increased production of IL-13 in conjunctiva. CONCLUSIONS: Topical application of MZR could alleviate epithelial damage and CD4+ T-cell-mediated immunity in ocular surface of DED.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhang X, Lin X, Liu Z, et al. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye. Invest Ophthalmol Vis Sci. 2017. PMID: 29204644. doi:10.1167/iovs.17-22852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。